Myriad Genetics, Inc. (MYGN)

Overview News Price History Option Chain Financials Why MYGN Down? Discussions Forecast Stock Split

Why is Myriad Genetics, Inc. (MYGN) Stock down?

We've noticed a 5.44% decline in Myriad Genetics, Inc. (MYGN) stock during the 2024-04-12 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!

09 Nov, 2023:

Shares of Myriad Genetics (MYGN) dropped by 8.94% from $17.89 to $16.29 in the trading on Thursday, Novemeber 9, 2023. The reason why MYGN down is due to the announcement of an upsized underwritten public offering of 6,470,588 shares of common stock at $17.00 per share, with expected gross proceeds of approximately $110 million. The company intends to use the net proceeds to repay loans, settle litigation, and support working capital and general corporate purposes. The offering is managed by Goldman Sachs & Co. LLC, Morgan Stanley, and Wells Fargo Securities and is subject to customary closing conditions.